Clinical Trials Browser

Phase 3 × Parasomnias × Melatonin × Clear all

NCT01906866 2024-04-23

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Phase 3 Completed

125 enrolled 22 charts

Autism Spectrum Disorder, Sleep Wake Disorders, Tuberous Sclerosis, Angelman Syndrome, Parasomnias, Smith-Magenis Syndrome

NCT01700959 2018-06-28

Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort

Phase 3 Completed

911 enrolled 15 charts

Parasomnias